Cargando…
The end of balloons? Our take on the UK-REBOA trial
BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is increasingly used. The recently published UK-REBOA trial aimed to investigate patients suffering haemorrhagic shock and randomized to standard care alone or REBOA as adjunct to standard care and concludes that REBOA may...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619299/ https://www.ncbi.nlm.nih.gov/pubmed/37908007 http://dx.doi.org/10.1186/s13049-023-01142-5 |
_version_ | 1785129958298877952 |
---|---|
author | Brede, Jostein Rødseth Rehn, Marius |
author_facet | Brede, Jostein Rødseth Rehn, Marius |
author_sort | Brede, Jostein Rødseth |
collection | PubMed |
description | BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is increasingly used. The recently published UK-REBOA trial aimed to investigate patients suffering haemorrhagic shock and randomized to standard care alone or REBOA as adjunct to standard care and concludes that REBOA may increase the mortality. MAIN BODY: In this commentary we try to balance the discussion on use of REBOA and address limitations in the UK-REBOA trial that may have influenced the outcome of the study. CONCLUSION: The situation is complex, and the patients are in extremis. In summary, we do not think this is the end of balloons. |
format | Online Article Text |
id | pubmed-10619299 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106192992023-11-02 The end of balloons? Our take on the UK-REBOA trial Brede, Jostein Rødseth Rehn, Marius Scand J Trauma Resusc Emerg Med Commentary BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is increasingly used. The recently published UK-REBOA trial aimed to investigate patients suffering haemorrhagic shock and randomized to standard care alone or REBOA as adjunct to standard care and concludes that REBOA may increase the mortality. MAIN BODY: In this commentary we try to balance the discussion on use of REBOA and address limitations in the UK-REBOA trial that may have influenced the outcome of the study. CONCLUSION: The situation is complex, and the patients are in extremis. In summary, we do not think this is the end of balloons. BioMed Central 2023-10-31 /pmc/articles/PMC10619299/ /pubmed/37908007 http://dx.doi.org/10.1186/s13049-023-01142-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Commentary Brede, Jostein Rødseth Rehn, Marius The end of balloons? Our take on the UK-REBOA trial |
title | The end of balloons? Our take on the UK-REBOA trial |
title_full | The end of balloons? Our take on the UK-REBOA trial |
title_fullStr | The end of balloons? Our take on the UK-REBOA trial |
title_full_unstemmed | The end of balloons? Our take on the UK-REBOA trial |
title_short | The end of balloons? Our take on the UK-REBOA trial |
title_sort | end of balloons? our take on the uk-reboa trial |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619299/ https://www.ncbi.nlm.nih.gov/pubmed/37908007 http://dx.doi.org/10.1186/s13049-023-01142-5 |
work_keys_str_mv | AT bredejosteinrødseth theendofballoonsourtakeontheukreboatrial AT rehnmarius theendofballoonsourtakeontheukreboatrial AT bredejosteinrødseth endofballoonsourtakeontheukreboatrial AT rehnmarius endofballoonsourtakeontheukreboatrial |